Skip to main content
Casa Minerals Inc. logo

Casa Minerals Inc. — Investor Relations & Filings

Ticker · CASA TSXV Mining and quarrying
Filings indexed 300 across all filing types
Latest filing 2020-08-31 Regulatory Filings
Country CA Canada
Listing TSXV CASA

About Casa Minerals Inc.

https://www.casaminerals.com/

Casa Minerals Inc. is a mineral exploration and development company focused on acquiring and advancing undervalued projects in established mining jurisdictions across North America. The company primarily explores for gold, copper, and zinc. Its core activities are centered in two prominent regions: Arizona, USA, and British Columbia, Canada. The flagship asset is the Congress Project in Arizona, a historic vein gold producer located within the prolific Arizona Copper Belt, which is being explored for both high-grade gold and copper-gold porphyry potential. The company's strategy is to leverage its experienced management team to drive value through exploration and discovery.

Recent filings

Filing Released Lang Actions
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings
2020-08-31 English
Interim MD&A - English.pdf
Regulatory Filings
2020-08-31 English
Material change report - English.pdf
Regulatory Filings Classification · 95% confidence The document is a Form 51-102F3 Material Change Report, which is a regulatory filing used to disclose material changes affecting the company. The content announces the passing of a director, James Clucas, which is a significant event but not a full report like an annual or interim report. The document length is 3756 characters, which is relatively short and primarily serves as a notification rather than a detailed report. It does not contain financial statements or detailed management discussion. The nature of the document fits best under Regulatory Filings (RNS) as it is a formal disclosure of a material event without being a full report or announcement of voting results or management changes in the board structure per se. Therefore, the classification is RNS with high confidence.
2020-08-19 English
News release - English.pdf
Board/Management Information Classification · 95% confidence The document is a company announcement regarding the passing of a director, James Clucas. It includes biographical information and condolences from the CEO and Board. There is no financial data, no mention of a report or meeting, no voting results, no regulatory filings, or other financial or governance disclosures. The content is about a change in the board due to the death of a director, which fits the category of Board/Management Information (MANG). The document length is short and it is not an announcement of a report publication or a certification. Therefore, the appropriate classification is MANG with high confidence.
2020-08-18 English
Other.pdf
Regulatory Filings Classification · 95% confidence The document is titled 'Directors' Resolutions' and contains resolutions approving the interim financial statements and Management's Discussion and Analysis (MD&A) for the period ended March 31, 2020. The document is short (1123 characters) and primarily records the approval of financial statements by the board, rather than presenting the financial statements or MD&A themselves. It does not contain actual financial data or substantive analysis, only the approval of such reports. Therefore, it is not the Interim/Quarterly Report (IR) itself but rather a formal board approval document. Given the nature and length, this fits best under Regulatory Filings (RNS), which covers miscellaneous regulatory announcements and certifications that do not fit other categories.
2020-06-01 English
Other.pdf
Regulatory Filings Classification · 95% confidence The document is titled 'Directors' Resolutions' and contains resolutions approving the interim financial statements and Management's Discussion and Analysis (MD&A) for the period ended March 31, 2020. The document is short (1123 characters) and primarily records the approval of interim financial statements by the board, rather than presenting the financial statements or MD&A themselves. It does not contain actual financial data or substantive financial analysis, only the approval of such reports. Therefore, it is not the interim report itself but a board resolution related to it. Given the short length and nature, this fits best as a Regulatory Filing (RNS) rather than an Interim Report (IR) or Management Report (MDA).
2020-06-01 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.